Students, faculty and activists have pressured the school to part ways with the Sackler family amid allegations that Purdue Pharma aggressively pushed OxyContin despite its addiction risks.
By Collin Binkley, Associated Press
The U.S. opioid epidemic has taken hundreds of thousands of lives. A reckoning for the manufacturers, marketers and distributors of these drugs has now begun -- but despite several multibillion dollar settlements, some states and municipalities say accountability and transparency…
Some states have made it clear they intend to continue their lawsuits against members of the Sackler family in state courts.
By Geoff Mulvihill, Associated Press
The American opioid crisis has left a lethal mark. Experts estimate as many as 400,000 people may have died from overdoses and related problems in the past several decades. Now, more than 20 states appear to have reached a comprehensive…
By Associated Press
At the Louvre's Oriental Antiquities gallery, tape is covering multiple placards bearing the name that has long been associated with arts patronage around the world.
Pressure is increasingly being applied to institutions benefiting from philanthropy to be accountable for their funding sources. Lately, the opioid epidemic has highlighted that dilemma: New York's famed Metropolitan Museum of Art is the latest museum to turn down money…
By Geoff Mulvihill, Alanna Durkin Richer, Associated Press
The Sackler family says a lawsuit filed by Massachusetts Attorney General Maura Healey that accuses Connecticut-based Purdue Pharma and the family of hiding the risks of opioids from doctors and patients is riddled with inaccurate and misleading statements.
The Sackler family, once known for philanthropy, has been embroiled in lawsuits and settlements to keep details of its pharmaceutical company's activities out of public view. Purdue Pharma is the maker of the highly addictive opioid OxyContin. Author and former…
By PBS NewsHour
On this edition for Sunday, Jan. 20, no compromise in sight as the government shutdown enters day 30, and troubling details emerge on how Purdue Pharma allegedly marketed prescription painkiller OxyContin. Also, after two decades, a paralyzed outdoorsman designs a…
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.